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ABSTRACT
Expression Atlas (http://www.ebi.ac.uk/gxa) is a
value-added database providing information about
gene, protein and splice variant expression in differ-
ent cell types, organism parts, developmental stages,
diseases and other biological and experimental con-
ditions. The database consists of selected high-
quality microarray and RNA-sequencing experiments
from ArrayExpress that have been manually curated,
annotated with Experimental Factor Ontology terms
and processed using standardized microarray and
RNA-sequencing analysis methods. The new version
of Expression Atlas introduces the concept of
‘baseline’ expression, i.e. gene and splice variant
abundance levels in healthy or untreated conditions,
such as tissues or cell types. Differential gene expres-
sion data benefit from an in-depth curation of experi-
mental intent, resulting in biologically meaningful
‘contrasts’, i.e. instances of differential pairwise com-
parisons between two sets of biological replicates.
Other novel aspects of Expression Atlas are its
strict quality control of raw experimental data, up-
to-date RNA-sequencing analysis methods, expres-
sion data at the level of gene sets, as well as genes
and a more powerful search interface designed to
maximize the biological value provided to the user.
INTRODUCTION
Expression Atlas is a further development of our previous
version of Gene Expression Atlas (1), launched by the
European Bioinformatics Institute (EBI) in 2008, and con-
tinues its original remit as a value-added database for
querying differential gene expression across tissues, cell
types and cell lines under various biological conditions.
These include developmental stages, physiological states,
phenotypes and diseases and cover multiple organisms.
Expression Atlas is developed with a view to accommo-
date data from multi-omics experiments, such as prote-
omics. High-quality microarray and RNA-sequencing
data in Expression Atlas continues to come from
ArrayExpress (2), including data imported from GEO
(3). Differential expression is reported for both coding
and non-coding transcripts. The sample attributes and
experimental factors (i.e. conditions under study) are
systematized and mapped to the Experimental Factor
Ontology [EFO (4)].
In particular, Expression Atlas introduces the concept
of baseline expression—the abundance of each gene and
splice variant in healthy or untreated tissues, cell types or
cellular components. Baseline expression is reported
within a species-speciﬁc context of selected large RNA-
sequencing experiments and provides a useful reference
for the user when considering differential expression data.
Expression Atlas continues to analyse and report stat-
istically robust differential expression for both coding and
non-coding transcripts. However, the biological relevance
of these data has been vastly improved due to an in-depth
manual curation of the experimental intent that for each
differential experiment yields a set of ‘contrasts’, i.e. in-
stances of differential pairwise comparisons between two
sets of biological replicates—the ‘reference’ (e.g. ‘healthy’
or ‘wild type’) set and a ‘test’ set (e.g. ‘diseased’ or
‘mutant’). Each of these sets is typically described by a
number of sample attributes and experimental factors.
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For example, all biological replicates treated with a test
compound may be compared with untreated samples.
Statistical analysis is then performed, providing P-values
and, (for microarray only) t-statistics, linking each gene to
differential contrasts in each experiment.
Another novel aspect of Expression Atlas is its focus on
quality control of raw experimental data and of experi-
mental design. A minimum acceptable number of biolo-
gical sample replicates (three) is also enforced to ensure
sufﬁcient statistical power to detect differential expression.
Before submission into analysis pipelines, all experimental
raw data undergo quality control. In the case of RNA-
sequencing experiments, poor quality reads and those
originating from contamination are excluded from
further analysis. Outlier arrays in microarray experiments
are also removed before manual contrast identiﬁcation
and statistical analysis.
The focus on the quality of raw data and experimental
design has led to exclusion of low-quality experiments.
The manual curation of contrasts for all eligible experi-
ments is also on-going, leading to a temporary reduction
in the number of experiments in Expression Atlas.
Support of reproducible analysis is provided for each
experiment by listing analysis methods and versions used
for processing its raw data, offering links to source code
where possible, as well as showing the version of Ensembl
genome reference used for mapping (for RNA-sequencing
experiments), and the version of miRBase (5) release from
which probe-set to microRNA mappings was taken for
microRNA microarray experiments. The user should
thus be able to reproduce the results presented in
Expression Atlas, by analysing the raw experimental
data using the methods listed for that experiment.
Expression Atlas search interface allows for querying
gene, splice variant or protein attributes (including
organism), at the level of individual genes or whole gene
sets. The user can also search for sample attributes and
experimental factors. Both baseline and differential com-
ponents of Expression Atlas are queried by default. The
experiments returned are those in which the queried
sample attributes match either the studied healthy or un-
treated biological conditions, e.g. tissues or cell types
(baseline expression), or match either a ‘test’ or a ‘refer-
ence’ side of a differential contrast (differential expres-
sion). Finally, the set of queried experiments can be
restricted by providing a list of accessions, keywords or
the species of samples studied in them.
The RNA-seq processing pipeline used to generate data
for Expression Atlas is shown in Figure 1. The full details
of material and methods used to generate expression data
shown in Expression Atlas interface are available in the
Supplementary Material.
RESULTS
Data
As of 24 September 13, Expression Atlas contains highly
curated data from 214 experiments, including four baseline
RNA-sequencing experiments (nine species) and 210 differ-
ential experiments (13 species). Baseline experiments
include Illumina Body Map (http://www.ebi.ac.uk/gxa/
experiments/E-MTAB-513) and Encode Cell Lines (http://
www.ebi.ac.uk/gxa/experiments/E-GEOD-26284). Differ-
ential experiments include 10 RNA-sequencing and 200
microarray experiments—mainly single-channel experi-
ments performed on gene arrays. Finally, microarray ex-
periments studying microRNAs are also available (e.g.
http://www.ebi.ac.uk/gxa/experiments/E-TABM-713).
New user interface features
Expression Atlas offers a separate page for each experi-
ment, as well as pages presenting baseline and differential
expression data for each gene, protein, gene set (e.g.
REACTOME pathway) and experimental condition (e.g.
‘heart’) stored in Atlas.
Baseline expression (Figure 2)
Users can search a baseline experiment with gene names,
protein accessions, gene, protein or splice variant identi-
ﬁers, keywords, biotypes (e.g. ‘protein coding’), GO and
InterPro terms as well as Reactome pathway IDs.
Optionally, each term (e.g. REACTOME pathway ID)
can be interpreted as a gene set, offering the user an
aggregated expression level across all genes in each
queried gene set. Users may also search using studied ex-
perimental conditions (e.g. tissue in Figure 2). By default,
search results are ordered such that genes that are most
speciﬁcally expressed in the experimental condition(s) of
interest are at the top. This is implemented by rewarding
higher expression in the conditions of interest and as low as
possible expression in the remaining conditions.
Optionally, the user may wish to search for ‘non-speciﬁc’
expression—in this scenario genes with high expression in
query conditions are not only rewarded but also not
penalized for high expression in non-query conditions.
This type of query typically returns ‘house-keeping’ genes
at the top of the results table, i.e. those with high levels of
expression in the majority of experimental conditions.
Expression levels below the displayed FPKM cut-off (0.5
by default) are treated as background (i.e. ‘noise’). The user
is free to select a different expression level cut-off—a histo-
gram breaking down the number of genes expressed above
a given cut-off is included to help the user decide which cut-
off to use for their query of interest. As FPKMs are already
a gross approximation of gene expression, the resulting
matrix encodes the expression level by way of a heatmap,
though the actual FPKM values can be displayed and are
downloadable from the experiment page. Finally, clicking
on a non-empty heatmap cell shows a breakdown of the
three most abundant splice variants for the corresponding
gene and experimental condition.
Differential expression (Figure 3)
Users may search a differential experiment by the same
gene properties and keywords as listed earlier in text
for baseline experiments, additionally selecting the type
of differential expression of interest (up/down by
default). A differential contrast dropdown is also avail-
able—the default search is for differential expression in
any contrast, but the user can also choose one or more
contrast of interest. By default, the search returns ﬁrst
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Figure 1. The RNA-seq processing pipeline used to generate data for Expression Atlas. The experimental metadata is retrieved from ArrayExpress.
The raw FASTQ ﬁles, retrieved from European Nucleotide Archive, undergo a quality control procedure via FASTQC package to remove low-
quality reads and uncalled bases. Subsequently, contaminated reads (e.g. bacterial in the cases of vertebrate samples) are removed. TopHat 1 is used
for mapping the reads to the reference genome, Cufﬂinks 1 quantiﬁes baseline expression for genes and transcripts and HTseq quantiﬁes expression
used for subsequent differential expression analysis with DESeq. The ﬁnal (summarized) baseline expression count for a gene in a condition is a
median across ﬁrst technical replicates, then across biological replicates corresponding to that condition.
Figure 2. Example baseline expression experiment page, with help annotations—Illumina Body Map. (For further information see: http://www.ebi.ac.
uk/gxa/help/baseline-atlas.html).
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genes that are differentially expressed most speciﬁcally in
the queried contrast(s). This is achieved by promoting to
the top genes with lowest P-values in the contrast(s) of
interest and at the same time penalizing genes with low
P-values in the remaining contrasts. Optionally, the user
may perform a ‘non-speciﬁc’ search, in which genes with
lowest P-values in the selected contrast(s) come ﬁrst, irre-
spective of whether they are reported with low P-values in
the remaining contrasts. The results of this analysis are
presented to the user in a matrix, with genes (and design
elements—for microarray only) as row labels, and con-
trasts as column labels. The results are sorted by
P-value; the t-statistics and log2-fold changes are also
available. As part of the differential analysis, ‘MA’ plots
are shown for the default FDR of 0.05. The user is able to
choose a different FDR and observe in the resulting
matrix, what effect this has had on the results. The differ-
ential experiment page offers downloads of analytics data
as well as raw counts (RNA-sequencing), normalized ex-
pression values (one-colour microarray) and log2-ratios
(two-colour microarray), respectively. Finally, experimen-
tal conditions for each contrast can be viewed via mouse-
over on contrast column headers, in the results matrix,
and on the experiment design page, available via a
button in the top-right corner of the experiment page.
Gene/protein/gene-set page
For each gene, protein and gene set (e.g. Reactome
pathway ID), Expression Atlas provides a summary page
that contains, at most, three separate panes (Figure 4). The
top pane contains extensive annotation for the represented
bio-entity, including links to external resources, its
orthologues and so forth. The middle pane shows
baseline expression information from the representative
baseline experiment in which the bio-entity was studied.
For gene sets, the aggregated expression levels across all
genes in the set are shown for each experimental condition.
Finally, the bottom pane (Figure 5) shows differential ex-
pression, sorted by P-value, across all contrasts in experi-
ments available in Expression Atlas. Mouse-over on a
contrast description shows experimental conditions
describing the test and the reference sides of that contrast
(shown in Figure 5 for the top contrast); clicking on a
contrast takes the user to the page of the experiment
from which the analytics were retrieved.
Experiment list page
This page (http://www.ebi.ac.uk/gxa/experiments)
presents a sortable and searchable list of all experiments
currently loaded in Expression Atlas, documenting,
among other things, experiment type (baseline or differen-
tial), the number of assays analysed for that experiment,
the organisms and experimental conditions studied, the
number of contrasts identiﬁed (differential experiments
only) and the array designs used in the experiment (micro-
array only).
Atlas infrastructure developments
Software availability
The Expression Atlas software is designed to run in-house
only. However, the software source code can be accessed
via http://github.com/gxa/atlas.
Figure 3. Example differential expression page, with help annotations—Transcription proﬁling by array of Drosophila melanogaster CDK8 and Cyclin
C homozygous mutants, determined using ‘Affymetrix GeneChip Drosophila Genome 2.0 Array’. (For further information see: http://www.ebi.ac.
uk/gxa/help/differential-atlas.html). Genes that were called as differentially expressed at FDR< 0.05 are shown in red in the MA plot.
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Release process
Gene Expression Atlas, described in our previous update,
released its data and software on a monthly basis.
Expression Atlas will also release data regularly, providing
individual experimental data and tar-gzip snapshots of all
the data (for ease of download) on the EMBL-EBI FTP
server (ftp://ftp.ebi.ac.uk/pub/databases/microarray/data/
atlas). The web services software will be released regularly,
with appropriate release notes notifying users of function-
ality changes.
FUTURE DIRECTIONS
Protein expression
Expression Atlas is intended as a multiomics, and in par-
ticular as a functional genomics and proteomics, resource,
incorporating expression of not only genes but also splice
variants and proteins. Although the quantitation and stat-
istical analysis of gene expression methods is relatively
mature and well established, the equivalent methods for
protein detection, quantiﬁcation and statistical analysis
are still active areas of research. Consequently, in the
ﬁrst instance, we will include protein expression data as
additional information to the transcriptomics data in the
baseline component of Expression Atlas only. EFO will be
used to identify data sets with corresponding sample de-
scriptions in PRIDE database (6). Expression of each
protein in those sets will be shown within the context of
the baseline expression of the particular gene coding for
the protein in the corresponding experimental condition.
Appropriate provenance will be attributed to each source
of protein expression data within Expression Atlas
interface.
Baseline expression data improvements
We plan to increase our baseline expression coverage to
experiments in novel species, containing greater resolution
of studied factors, e.g. tissues, as well as with greater bio-
logical replication of studied samples—in aid of more
robust analysis results presented to the user. The
baseline expression analysis will also include data sets
that study heterogeneity among individuals and, for
example, tissues, focusing on variation data, expression
quantitative trait loci and mutations.
Expression visualization improvements
We will make transcript expression levels more prominent
in our experiment pages, focusing on genome browser
coverage views of expression—allowing the user to
Figure 4. Baseline expression on summary page example for human BRCA1 gene: http://www.ebi.ac.uk/gxa/genes/ENSG00000012048.
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observe in detail how expression is distributed across dif-
ferent exons and transcripts of a given gene.
Baseline expression aggregation
We are working on methods to aggregate expressions of a
gene, in a given experimental condition, across all applic-
able RNA-sequencing experiments, so that a single expres-
sion level for that ‘gene-experimental condition’
combination can be shown to the user.
Gene set enrichment analysis
Currently, only baseline expression summaries for gene
sets are offered in Expression Atlas interface. Pre-
computed gene set enrichment analysis results in the
context of differential expression will be offered, for
example, InterPro, GO terms and REACTOME
pathways. The results of this analysis will be shown in
the corresponding gene set summary page. Users will
also be able to submit an arbitrary set of genes to
quantify enrichment against all contrasts/differential
gene sets present in Expression Atlas. Such queries may
be submitted together with experimental conditions to
restrict the set of contrasts to analyse the enrichment in.
Hom(e)ologue expression
The Expression Atlas interface will facilitate gene co-ex-
pression analysis, including paralogues and homeologues
where applicable, as well as comparative analysis of
expression of orthologues.
MicroRNA RNA-sequencing experiments
The pipeline used to process RNA-sequencing data for
Expression Atlas will be enhanced to analyse microRNA
RNA-sequencing experiments. Subsequently, good quality
microRNA RNA-sequencing experiments available in
ArrayExpress will be re-processed and included in
Expression Atlas.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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